Product Name:

CDK5-pY15


Product Number:

ab-pk572

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Cyclin-dependent protein-serine kinase 5

Target Alias: Cell division protein kinase 5; CRK6; PSSALRE; TAU protein kinase II; TPKII; ENSG00000164885

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK570

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: Y15

Protein UniProt: Q00535

Protein SigNET: Q00535

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human CDK5 sequence peptide Cat. No.: PE-04AJO95

Antibody Immunogen Sequence: EGT(pY)GTV(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.

Production Method: Corresponds to amino acid residues E12 to V18; In the protein kinase catalytic domain in subdomain I.

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 0.5 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 29-35 kDa.

Antibody Specificity: Very high

Antibody Cross Reactivity: No significant cross-reactive proteins detected in A431 cells and sea star oocytes.

Scientific Background: CDK5 is a protein-serine/threonine kinase of the CMGC group and CDK family. It is required for cell cycle arrest in neuronal cells. It is activated by binding p35 protein. Phosphorylation at S159 increases phosphotransferase activity. Phosphorylation at T14 and Y15 inhibits phosphotransferase activity. CDK5 has been observed to be proline-directed and to phosphorylate SRC, NOS3, VIM/vimentin, p35/CDK5R1, MEF2A, SIPA1L1, SH3GLB1, PXN, PAK1, MCAM/MUC18, SEPT5, SYN1, DNM1, AMPH, SYNJ1, CDK16, RAC1, RHOA, CDC42, TONEBP/NFAT5, MAPT/TAU, MAP1B, histone H1, p53/TP53, HDAC1, APEX1, PTK2/FAK1, huntingtin/HTT, ATM, MAP2, NEFH and NEFM. CDK5 has been implicated in Aneurysmal bone cyst, which is a bone cancer that will affect bone, endothelial tissue, and bone marrow.